Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Journal of Alzheimer'S Disease : JAD|December 16, 2010
Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's diseaseAndrew D Watt, Keyla A Perez, Noel G Faux, et al.
Brain Imaging and Behavior|October 19, 2011
Amyloid imaging in Alzheimer's disease and other dementiasMichelle T Fodero-Tavoletti, Roberto Cappai, Catriona A McLean, et al.
Neuropsychologia|May 3, 2011
Cognition and beta-amyloid in preclinical Alzheimer's disease: data from the AIBL studyKerryn E Pike, Kathryn A Ellis, Victor L Villemagne, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivoC Sgadari, A L Angiolillo, B W Cherney, et al.
Neuro-Oncology Practice|September 18, 2023
Exploring the clinical utility of a brief screening measure of unmet supportive care needs in people with high-grade gliomaRachel Campbell, Mona Faris, Joanne Shaw, et al.
Brain : a Journal of Neurology|February 12, 2011
Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's diseaseGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
Annals of Neurology|April 8, 2010
Relationship between atrophy and beta-amyloid deposition in Alzheimer diseaseGaël Chételat, Victor L Villemagne, Pierrick Bourgeat, et al.
Brain : a Journal of Neurology|August 27, 2010
Larger temporal volume in elderly with high versus low beta-amyloid depositionGaël Chételat, Victor L Villemagne, Kerryn E Pike, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 7, 2010
Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's diseaseVictor L Villemagne, Keyla A Perez, Kerryn E Pike, et al.
Pageof 14